NCT07150312 is a NA clinical trial of HIIT in Esports Players, sponsored by Ma Ruisi.

Who is sponsoring NCT07150312?

NCT07150312 is sponsored by Ma Ruisi.

What drugs are being tested in NCT07150312?

Interventions in NCT07150312: HIIT, MICT.

What condition does NCT07150312 study?

NCT07150312 studies Esports Players.

Is NCT07150312 still recruiting?

NCT07150312 is currently not yet recruiting. Last updated 2 September 2025.

Last reviewed 2025-09-02 · How we verify

NCT07150312

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Can Different Exercise Modalities Improve Esports Performance?

Not yet recruiting NA Last updated 2 September 2025

What this trial tests

NA trial testing HIIT in Esports Players in 195 participants. Not yet recruiting.

Timeline

1 January 2026

Primary endpoint
31 March 2028

31 December 2028

Quick facts

Lead sponsor	Ma Ruisi
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	195
Start date	1 January 2026
Primary completion	31 March 2028
Estimated completion	31 December 2028

Drugs / interventions tested

HIIT
MICT

Conditions studied

Esports Players — all drugs for Esports Players →

Sponsor

Ma Ruisi

Who can join

18 and older, any sex, with Esports Players. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the long-term effects of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) on esports performance through a 12-week three-arm randomized controlled trial, and to examine the sustainability of these effects during a follow-up period after intervention cessation. Additionally, we seek to compare the differential impacts of these two exercise modalities on various dimensions of esports performance, thereby providing evidence-based guidance for esports training regimens and enhancing our understanding of the underlying mechanisms by which different exercise approaches influence cognitive and motor capabilities essential for competitive gaming.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of HIIT

Trials testing the same drug.

NCT07273058 — Effect of HIIT on Post-Stroke Fatigue · NA · recruiting
NCT07177963 — CPET-based HIIT for MAFLD · NA · not yet recruiting
NCT06951620 — Optimizing Aerobic Fitness in Older Adults · NA · recruiting
NCT06727500 — Effects of HIIT and Concurrent HITT/Plyometric Training on Muscle-tendon Structure, Function and Metabolism in Pediatric · NA · recruiting
NCT06528639 — A Clinical Study on Exercise Guided by CPET to Reduce the Risk of Metabolic Cardiovascular Diseases（C-MET Trial） · NA · recruiting

Other Ma Ruisi trials

Trials by the same sponsor.

NCT07256847 — Effect of 6-Week High Intensity Interval Training on VO2max, Physical Competence and Sleep Quality in Sedentary Male Uni · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07150312 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ma Ruisi
Last refreshed: 2 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07150312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing